"We're not trying to make money. We just want to see people get vaccinated."
Cobervax is an open-source alternative to Big Pharma's patent-protected vaccines. Instead of being produced for profit, this shot could ultimately be manufactured around the world and made cheaply available to all.
Texas Children's Hospital, Houston's Baylor College, and the Indian pharmaceutical company Biological E. Limited says the new vaccine is at least 90% effective against the SARS-CoV-2 virus, and 80% or more effective against its Delta variant. The ambition is to create a low-cost, open-source alternative to expensive and limited-supply mRNA vaccines for developing and under-vaccinated countries.
Peter Hotez and Maria Elena Bottazzi won't personally profit from vaccine which they were instrumental in developing.
"Our Texas Children's Center does not plan to make money on this, it's a gift to the world."
No comments:
Post a Comment